[ Back to EurekAlert! ]

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute

Myles Brown, Dana-Farber Cancer Institute

Caption: Myles Brown, MD, and colleagues at Dana-Farber Cancer Institute have discovered a molecular switch that enables advanced prostate cancers to spread without stimulation by male hormones, which normally are needed to spur the cancerís growth. The previously unknown protein function could serve as a treatment target for prostate cancers that are no longer controlled by hormone-blocking drugs, according to the researchers.

Credit: Sam Ogden

Usage Restrictions: None

Related news release: Researchers find new culprit in castration-resistant prostate cancer


[ Back to EurekAlert! ]